Biosimilar show a good development prospect, while drug research and development cost is spiralling

doi:10.3981/j.issn.1000-7857.2017.01.013

PDF(1391 KB)

Science & Technology Review ›› 2017, Vol. 35 ›› Issue (1) : 107-112. DOI: 10.3981/j.issn.1000-7857.2017.01.013

Spescial Issues

Biosimilar show a good development prospect, while drug research and development cost is spiralling

{{article.zuoZhe_EN}}

Author information -

About authors:

Corresponding authors:

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 35(1): 107-112 https://doi.org/10.3981/j.issn.1000-7857.2017.01.013

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1391 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export